Analysis of the Factors Associated with Abnormal Coagulation and Prognosis in Patients with Non-small Cell Lung Cancer
Background and objective The activation of coagulation and fibrinolysis is frequently encountered among cancer patients. Such tumors are associated with high risk of invasion, metastases, and negative final outcomes. Non-small cell lung cancer (NSCLC) accounts for approximately 80% to 85% of all lun...
Main Authors: | Yanhua LI, Suju WEI, Junyan WANG, Lei HONG, Lige CUI, Cai WANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-11-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.04 |
Similar Items
-
Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients
by: Kovač Mirjana, et al.
Published: (2022-01-01) -
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination
by: Metodija Sekulovski, et al.
Published: (2023-10-01) -
Clinicopathologic features and prognosis of 71 patients with gastric cancer and disseminated intravascular coagulation
by: Ling Chen, et al.
Published: (2023-11-01) -
An investigation to find the correlation between lupus anticoagulant and coagulation abnormalities in COVID-19 patients; a narrative review
by: Amir Aria, et al.
Published: (2024-01-01) -
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
by: Eric Manderstedt, et al.
Published: (2022-10-01)